Citalopram (CITALOPRAM HYDROBROMIDE)
Citalopram (CITALOPRAM HYDROBROMIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Citalopram; Generic name: CITALOPRAM HYDROBROMIDE; Manufacturer: REMEDYREPACK INC..
| Brand name | Citalopram |
|---|---|
| Generic name | CITALOPRAM HYDROBROMIDE |
| Manufacturer | REMEDYREPACK INC. |
| Used for | 1 INDICATIONS AND USAGE Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ] . Citalopram tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) in adults ( 1 ) . |
| Dosage | 2 DOSAGE AND ADMINISTRATION Administer once daily with or without food ( 2 ) . Initial dosage is 20 mg once daily; after one week may increase to maximum dosage of 40 mg once daily ( 2.1 ). Patients greater than 60 years of age, patients with hepatic impairment, and CYP2C19 poor metabolizers: maximum recommended dosage is 20 mg once daily ( 2.2 ). When discontinuing citalopram tablets, reduce dosage gradually ( 2.4 , 5.6 ). 2.1 Recommended Dosage Administer citalopram tablets once daily, with or |
| Warnings | WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions (5.1) ] . Citalopram is not approved for use in pediatric patients [see Use in Specific Populations (8.4) ]. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescribin |
| Active ingredient(s) | CITALOPRAM HYDROBROMIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0109f365-bebd-4810-a56f-4451e10245db |